Clinical Trial Update: NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC [Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 2 neoadjuvant study of toripalimab plus 9MW2821 for local upper tract urothelial carcinoma, currently not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Drugs mentioned

• 9MW2821
• Toripalimab (Toripalimab)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Upper Tract Urothelial Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING